Literature DB >> 31565761

Could or Should We Use MCDA in the French HTA Process?

Salah Ghabri1, Jean-Michel Josselin2, Benoît Le Maux2.   

Abstract

Entities:  

Year:  2019        PMID： 31565761     DOI： 10.1007/s40273-019-00846-w

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  13 in total

1.  Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting.

Authors:  Nicolas Martelli; Paul Hansen; Hélène van den Brink; Aurélie Boudard; Anne-Laure Cordonnier; Capucine Devaux; Judith Pineau; Patrice Prognon; Isabelle Borget
Journal:  J Biomed Inform       Date:  2015-12-15       Impact factor: 6.317

2.  Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.

Authors:  Aris Angelis; Panos Kanavos
Journal:  Soc Sci Med       Date:  2017-06-20       Impact factor: 4.634

3.  Multicriteria decision analysis for including health interventions in the universal health coverage benefit package in Thailand.

Authors:  Sitaporn Youngkong; Rob Baltussen; Sripen Tantivess; Adun Mohara; Yot Teerawattananon
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

4.  Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.

Authors:  Mireille M Goetghebeur; Monika Wagner; Hanane Khoury; Randy J Levitt; Lonny J Erickson; Donna Rindress
Journal:  Med Decis Making       Date:  2011-10-10       Impact factor: 2.583

5.  Multicriteria decision analysis in the reimbursement of new medical technologies: real-world experiences from Hungary.

Authors:  Dóra Endrei; Bálint Molics; István Agoston
Journal:  Value Health       Date:  2014-04-29       Impact factor: 5.725

Review 6.  Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature.

Authors:  Kevin Marsh; Tereza Lanitis; David Neasham; Panagiotis Orfanos; Jaime Caro
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

7.  Implementation of EUnetHTA core Model® in Lombardia: the VTS framework.

Authors:  Giovanni Radaelli; Emanuele Lettieri; Cristina Masella; Luca Merlino; Alberto Strada; Michele Tringali
Journal:  Int J Technol Assess Health Care       Date:  2014-01-22       Impact factor: 2.188

8.  The Use of MCDA in HTA: Great Potential, but More Effort Needed.

Authors:  Kevin D Marsh; Mark Sculpher; J Jaime Caro; Tommi Tervonen
Journal:  Value Health       Date:  2017-11-22       Impact factor: 5.725

9.  Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.

Authors:  Praveen Thokala; Nancy Devlin; Kevin Marsh; Rob Baltussen; Meindert Boysen; Zoltan Kalo; Thomas Longrenn; Filip Mussen; Stuart Peacock; John Watkins; Maarten Ijzerman
Journal:  Value Health       Date:  2016-01-08       Impact factor: 5.725

10.  Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment.

Authors:  Aris Angelis; Panos Kanavos
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981
View more
  1 in total

1.  Feasibility of Measuring Preferences for Chemotherapy Among Early-Stage Breast Cancer Survivors Using a Direct Rank Ordering Multicriteria Decision Analysis Versus a Time Trade-Off.

Authors:  Laura Panattoni; Charles E Phelps; Tracy A Lieu; Stacey Alexeeff; Suzanne O'Neill; Jeanne S Mandelblatt; Scott D Ramsey
Journal:  Patient       Date:  2020-10       Impact factor: 3.883
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.